Medical Journals

Ews/Fli1 Regulates Tumor Angiogenesis in Ewing's Sarcoma Via Suppression of Thrombospondins.

Authors:
  • Potikyan Gary
  • Savene Rupert O V
  • Gaulden Julie M
  • France Kelly A
  • Zhou Zhichao
  • Kleinerman Eugenie S
  • Lessnick Stephen L
  • Denny Christopher T

From: Molecular Biology Institute, Jonsson Comprehensive Cancer Center, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90024, USA.

Cancer research

  • Publish Date: Jul 2007
  • ISSN: 0008-5472
  • Volume: 67
  • Issue: 14
  • Pages: 6675-84
  • Medium: Print
  • Language: English
  • Citation (JAMA): Potikyan Gary, Savene Rupert O V, Gaulden Julie M, et al. Ews/Fli1 Regulates Tumor Angiogenesis in Ewing's Sarcoma Via Suppression of Thrombospondins.. Cancer Res. Jul 2007;67:6675-84

Abstract

Suppression of the expression of antiangiogenic factors has been closely associated with multiple malignancies. Thrombospondins 1 and 2 are members of a family of angiogenic inhibitors that are regulated by several oncogenes. In this study, we investigate the role of thrombospondins in Ewing’s sarcoma and their regulation by EWS/ETS fusion oncoproteins. We show that the EWS/FLI1 fusion suppresses the expression of thrombospondins in both NIH3T3 fibroblasts and Ewing’s sarcoma tumor-derived cell lines. This regulation depends on an intact EWS/FLI1 DNA-binding domain and may involve direct interactions between EWS/FLI1 and thrombospondin promoter regions. Forced expression of thrombospondins in Ewing’s sarcoma cell lines inhibited the rate of tumor formation in vivo and markedly decreased the number of microvessels present in the tumors. These findings suggest that thrombospondins play a biologically significant role in tumor vascularization in Ewing’s sarcoma and suggest potential therapeutic strategies for future therapeutic intervention.

Mesh Headings (Keywords): Animals, Cell Line, Tumor, Gene Expression Regulation, Neoplastic, Humans, Mice, Mice, Nude, Models, Genetic, NIH 3T3 Cells, Neoplasm Transplantation, Neovascularization, Pathologic, Oligonucleotide Array Sequence Analysis, Oncogene Proteins, Fusion, Sarcoma, Ewing’s, Thrombospondins, Time Factors, Transcription Factors


Check for Full Text / PubMed Unique Identifier (PMID): 17638877


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.